273
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Discovery of new AKT1 inhibitors by combination of in silico structure based virtual screening approaches and biological evaluations

, , , , & ORCID Icon
Pages 368-377 | Received 02 Nov 2019, Accepted 03 Nov 2019, Published online: 12 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Vijay Kumar Veena, Ahana Roy Choudhury & Adhikesavan Harikrishnan. (2022) In vitro and in silico anti-leukemic activity of 2-amino-6-nitro-4-(4-oxo-2-thioxothiazolidin-5-yl)-4H-chromene-3-carbonitrile (ANC) through inhibition of anti-apoptotic Bcl-2 proteins. Journal of Biomolecular Structure and Dynamics 40:15, pages 7018-7026.
Read now
Adhikesavan Harikrishnan, V. Veena, B. Lakshmi, R. Shanmugavalli, Sonia Theres, C. N. Prashantha, Tanya Shah, K. Oshin, Ringu Togam & Sisir Nandi. (2021) Atranorin, an antimicrobial metabolite from lichen Parmotrema rampoddense exhibited in vitro anti-breast cancer activity through interaction with Akt activity. Journal of Biomolecular Structure and Dynamics 39:4, pages 1248-1258.
Read now

Articles from other publishers (3)

Huafeng Xu. (2022) The slow but steady rise of binding free energy calculations in drug discovery. Journal of Computer-Aided Molecular Design 37:2, pages 67-74.
Crossref
Eric R. Hantz & Steffen Lindert. (2022) Actives-Based Receptor Selection Strongly Increases the Success Rate in Structure-Based Drug Design and Leads to Identification of 22 Potent Cancer Inhibitors. Journal of Chemical Information and Modeling 62:22, pages 5675-5687.
Crossref
SM Bargeen Alam Turzo, Eric R. Hantz & Steffen Lindert. (2022) Applications of machine learning in computer-aided drug discovery. QRB Discovery 3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.